Overview
Also known as:
FDA & Trial Timeline
3 eventsNational University Hospital, Singapore — PHASE2
Clinica Universidad de Navarra, Universidad de Navarra — NA
Beijing Chest Hospital — PHASE1, PHASE2
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Central nervous system tuberculosis.
3 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Central nervous system tuberculosis.
Community
No community posts yet. Be the first to share your experience with Central nervous system tuberculosis.
Start the conversation →Latest news about Central nervous system tuberculosis
Disease timeline:
New recruiting trial: Advice of Moderate Drinking Pattern Versus Advice on Abstention on Major Disease and Mortality
A new clinical trial is recruiting patients for Central nervous system tuberculosis
New recruiting trial: Adjunctive Doxycycline for Central Nervous System Tuberculosis
A new clinical trial is recruiting patients for Central nervous system tuberculosis
New recruiting trial: Intensified Tuberculosis Treatment to Reduce the Mortality of Patients With Tuberculous Meningitis
A new clinical trial is recruiting patients for Central nervous system tuberculosis
New recruiting trial: Trial of a Six-Month Regimen of High-Dose Rifampicin, High-Dose Isoniazid, Linezolid, and Pyrazinamide Versus a Standard Nine-Month Regimen for the Treatment of Adults and Adolescents With Tuberculous Meningitis
A new clinical trial is recruiting patients for Central nervous system tuberculosis
New recruiting trial: Tnf Inhibitors to Reduce Mortality in HIV-1 Infected PAtients With Tuberculosis meNIngitis
A new clinical trial is recruiting patients for Central nervous system tuberculosis
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Central nervous system tuberculosis
Are there clinical trials for Central nervous system tuberculosis?
Yes — 3 recruiting clinical trials are currently listed for Central nervous system tuberculosis on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Central nervous system tuberculosis?
25 specialists and care centers treating Central nervous system tuberculosis are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.